Certified by Founder Lodge
Foresite Capital
United States - Larkspur, California
INVESTOR
1 Disclosed Funding Rounds $30,000,000
12 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Foresite Capital is a multi-stage healthcare and life sciences investment firm with ~ $3.5B in assets under management (as of 3/31/22). The firm aims to address areas of great unmet need by f
| Company | Date | Round | Raised |
|---|---|---|---|
 FOLX Health |
October, 17 ,2022 | Series B | $30,000,000 |
 Delfi Diagnostics |
July, 18 ,2022 | Series B | $225,000,000 |
 Evonetix Ltd |
February, 10 ,2023 | Series B | $24,000,000 |
 DNAnexus |
June, 09 ,2022 | Unknown | $100,000,000 |
 Mirvie |
May, 17 ,2022 | Series B | $60,000,000 |
 Foresight Diagnostics Inc. |
April, 28 ,2023 | Series B | $58,750,000 |
 Thyme Care |
August, 22 ,2023 | Series B | $60,000,000 |
 Odyssey Therapeutics |
December, 06 ,2023 | Series C | $101,000,000 |
 Remix Therapeutics |
January, 04 ,2024 | Unknown | $60,000,000 |
 Latigo Biotherapeutics, Inc. |
February, 15 ,2024 | Series A | $135,000,000 |
 FogPharma |
March, 05 ,2024 | Series E | $145,000,000 |
 Alumis |
March, 07 ,2024 | Series C | $259,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
OTPLESS | $3,500,000 | (May 17, 2024)
Watershed Health | $13,600,000 | (May 17, 2024)
Aeropay | $20,000,000 | (May 17, 2024)
c/side | $1,700,000 | (May 17, 2024)
SINE Digital | $2,500,000 | (May 17, 2024)
